Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Substudy of the CADRE Study: Determination of Clinical Markers in Patients With Extreme Sickle Cell Disease Phenotype

NCT03352986 is registered in ClinicalTrials.gov with Cardiologie et Développement as lead sponsor.

NCT NCT03352986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03352986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Substudy of the CADRE Study: Determination of Clinical Markers in Patients With Extreme Sickle Cell Disease Phenotype
Lead sponsor
Cardiologie et Développement
Phase
Observational
Overall status
Unknown status
Start date
May 15, 2017
Completion date
December 31, 2019
Enrollment
300 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease